Company Search:
Advanced Search
Sponsored Links
Symbio Pharmaceuticals Ltd Company Snapshot
Symbio Pharmaceuticals Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Symbio Pharmaceuticals Ltd with three other companies in this sector in Japan: Medical Data Vision Co Ltd (2018 sales of 3.58 billion Japanese Yen [US$32.91 million] of which 59% was Data profit utilization service), GNI Group Limited (5.02 billion Japanese Yen [US$46.17 million] of which 64% was Medicine Business), and Sosei Group Corporation (3.83 billion Japanese Yen [US$35.23 million] of which 100% was Pharmaseutical Business).

Sales Analysis. Symbio Pharmaceuticals Ltd reported sales of ¥3.84 billion (US$35.29 million) for the year ending December of 2018. This represents an increase of 11.4% versus 2017, when the company's sales were ¥3.44 billion. This was the third consecutive year of growth at Symbio Pharmaceuticals Ltd.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Symbio Pharmaceuticals Ltd
  Stock Performance Chart for Symbio Pharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 644.00
(Figures in Japanese Yen)
1 Week -8.7%   13 Weeks 4.9%  
4 Weeks 13.2%   52 Weeks -21.1%  
Symbio Pharmaceuticals Ltd Key Data:
  Ticker: 4582 Country: Japan
  Exchanges: TYO JSQ Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 3,835,530,000
(Year Ending Jan 2019).
Employees: 90
  Currency: Japanese Yen Market Cap: 15,689,554,972
  Fiscal Yr Ends: December Shares Outstanding: 24,362,663
  Share Type: Common Closely Held Shares: 2,195,525
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.